Robert J. Ignoffo

1.4k total citations
33 papers, 1.0k citations indexed

About

Robert J. Ignoffo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Robert J. Ignoffo has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Geriatrics and Gerontology. Recurrent topics in Robert J. Ignoffo's work include Cancer Treatment and Pharmacology (7 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Robert J. Ignoffo is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Colorectal Cancer Treatments and Studies (4 papers). Robert J. Ignoffo collaborates with scholars based in United States, Switzerland and Russia. Robert J. Ignoffo's co-authors include Michael Friedman, J. Rosenberg, Dana Lee, Marc A. Shuman, Kenneth Aldape, Antonio J Grillo-López, Lloyd E. Damon, James L. Rubenstein, Dan Combs and Michael McDermott and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Robert J. Ignoffo

31 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Ignoffo United States 14 390 243 217 213 161 33 1.0k
Prasanth Ganesan India 18 352 0.9× 197 0.8× 189 0.9× 69 0.3× 183 1.1× 144 1.1k
Vanita Noronha India 16 456 1.2× 174 0.7× 404 1.9× 54 0.3× 115 0.7× 97 1.0k
Martina Kleber Germany 15 527 1.4× 91 0.4× 117 0.5× 51 0.2× 151 0.9× 48 1.1k
Arben Lleshi Italy 18 420 1.1× 214 0.9× 108 0.5× 65 0.3× 55 0.3× 49 880
Shripad Banavali India 22 666 1.7× 193 0.8× 316 1.5× 93 0.4× 177 1.1× 170 2.0k
Quentin A. Hill United Kingdom 21 207 0.5× 228 0.9× 137 0.6× 106 0.5× 439 2.7× 60 1.8k
N. Maisey United Kingdom 15 671 1.7× 155 0.6× 326 1.5× 33 0.2× 46 0.3× 30 1.1k
Gaurav Prakash India 15 206 0.5× 189 0.8× 115 0.5× 96 0.5× 184 1.1× 173 818
Daris Ferrari Italy 24 836 2.1× 113 0.5× 585 2.7× 35 0.2× 120 0.7× 69 1.7k
Jonas Paludo United States 16 611 1.6× 295 1.2× 139 0.6× 78 0.4× 208 1.3× 150 1.2k

Countries citing papers authored by Robert J. Ignoffo

Since Specialization
Citations

This map shows the geographic impact of Robert J. Ignoffo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Ignoffo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Ignoffo more than expected).

Fields of papers citing papers by Robert J. Ignoffo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Ignoffo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Ignoffo. The network helps show where Robert J. Ignoffo may publish in the future.

Co-authorship network of co-authors of Robert J. Ignoffo

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Ignoffo. A scholar is included among the top collaborators of Robert J. Ignoffo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Ignoffo. Robert J. Ignoffo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ignoffo, Robert J., Katherine K. Knapp, & William M. Ellis. (2022). Board-certified pharmacy specialties: Growth from 2008 to 2020 and projections to 2025. American Journal of Health-System Pharmacy. 79(23). 2134–2140. 10 indexed citations
2.
Knapp, Katherine K. & Robert J. Ignoffo. (2020). Oncology Pharmacists Can Reduce the Projected Shortfall in Cancer Patient Visits: Projections for Years 2020 to 2025. SHILAP Revista de lepidopterología. 8(1). 43–43. 10 indexed citations
3.
Ignoffo, Robert J., et al.. (2017). Novel Systemic Therapies for Advanced Non–Small-Cell Lung Cancer. Touro Scholar (Touro College).
4.
Ignoffo, Robert J., et al.. (2017). Value Frameworks for the Patient-Provider Interaction: A Comparison of the ASCO Value Framework Versus NCCN Evidence Blocks in Determining Value in Oncology. Journal of Managed Care & Specialty Pharmacy. 23(6-a Suppl). S13–S20. 14 indexed citations
5.
Ignoffo, Robert J.. (2008). Current research on PONV/PDNV: Practical implications for today’s pharmacist. American Journal of Health-System Pharmacy. 66(1_Supplement_1). S19–S24. 2 indexed citations
6.
Ignoffo, Robert J.. (2004). Overview of Bevacizumab: A New Cancer Therapeutic Strategy Targeting Vascular Endothelial Growth Factor. American Journal of Health-System Pharmacy. 61(suppl_5). S21–S26. 55 indexed citations
7.
Ignoffo, Robert J., et al.. (2003). A guide to clinically relevant drug interactions in oncology. Journal of Oncology Pharmacy Practice. 9(2-3). 45–85. 28 indexed citations
8.
Beney, Johnny, et al.. (2002). Effect of Telephone Follow‐up on the Physical Well‐Being Dimension of Quality of Life in Patients with Cancer. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(10). 1301–1311. 17 indexed citations
9.
Spiegel, David, et al.. (2002). Improving the quality of life for patients with cancer through the cancer supportive care program and web site. Clinical Therapeutics. 24. 11–12. 1 indexed citations
10.
Ignoffo, Robert J., et al.. (2000). Temozolomide. Cancer Practice. 8(6). 311–313. 1 indexed citations
11.
Ignoffo, Robert J., et al.. (2000). Temozolomide. A New Option for High-Grade Astrocytomas. Cancer Practice. 8(6). 311–313. 4 indexed citations
12.
Ignoffo, Robert J.. (1999). Novel oral fluoropyrimidines in the treatment of metastatic colorectal cancer. American Journal of Health-System Pharmacy. 56(23). 2417–2428. 11 indexed citations
13.
Ignoffo, Robert J.. (1998). Capecitabine: A New Oral Fluoropyrimidine. Cancer Practice. 6(5). 302–304. 5 indexed citations
14.
Larson, Patricia J., Laurie A. MacPhail, Marylin J. Dodd, et al.. (1998). The PRO-SELF?? Mouth Aware program: An effective approach for reducing chemotherapy-induced mucositis. Cancer Nursing. 21(4). 263–268. 64 indexed citations
15.
Ignoffo, Robert J., et al.. (1995). Pharmaceutical care and the cancer patient. Journal of Oncology Pharmacy Practice. 1(4). 7–19. 2 indexed citations
16.
Ignoffo, Robert J.. (1992). Parenteral Nutrition Support in Patients With Cancer. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 12(4). 353–357. 2 indexed citations
17.
Hattersley, Paul G., et al.. (1983). Adjusting Heparin Infusion Rates from the Initial Response to Activated Coagulation Time. Drug Intelligence & Clinical Pharmacy. 17(9). 632–634. 10 indexed citations
18.
Coleman, C. Norman, Charlotte Jacobs, Joanne Halsey, et al.. (1983). Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.. PubMed. 43(10). 5022–5. 14 indexed citations
19.
Ignoffo, Robert J., et al.. (1981). Pharmacokinetics of methotrexate administered via the hepatic artery. Cancer Chemotherapy and Pharmacology. 5(4). 217–220. 8 indexed citations
20.
Friedman, Michael & Robert J. Ignoffo. (1980). A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958). Cancer Treatment Reviews. 7(4). 205–213. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prasanth Ganesan Breakdown of academic impact, for papers by Vanita Noronha Breakdown of academic impact, for papers by Martina Kleber Breakdown of academic impact, for papers by Arben Lleshi Breakdown of academic impact, for papers by Shripad Banavali Breakdown of academic impact, for papers by Quentin A. Hill Breakdown of academic impact, for papers by N. Maisey Breakdown of academic impact, for papers by Gaurav Prakash Breakdown of academic impact, for papers by Daris Ferrari Breakdown of academic impact, for papers by Jonas Paludo
Rankless by CCL
2026